ATLANTA — Axion BioSystems, a leading life sciences tools company focused on advanced live-cell assay systems, announces the acquisition of the Netherlands-based CytoSMART Technologies—an innovator in kinetic live-cell imaging analysis. The collaboration positions Axion for significant expansion in the fields of stem cell research, immuno-oncology, cell-based therapies, and drug discovery. Axion BioSystems Acquires Live-Cell Imaging Innovator […]

Cash Investment Expected to Significantly Advance Fluidigm’s Mission through New Growth Initiatives and Cost Structure Optimization SOUTH SAN FRANCISCO, Calif. — Fluidigm Corporation (NASDAQ:FLDM) today urged Fluidigm stockholders to vote “FOR” ALL proposals related to the previously announced strategic capital infusion from leading life sciences investors Casdin Capital, LLC (“Casdin”) and Viking Global Investors LP (“Viking”) at the Company’s upcoming […]

BOSTON — ABclonal Technology, a rapidly growing life science research and diagnostic reagents manufacturer, today announced it has joined the Industry Advisory Committee (IAC) at YCharOS Inc., an open science company with the mission of characterizing commercially available antibody reagents for all human proteins, to tackle the reproducibility crisis observed in biomedical research. Inconsistent antibody […]

Fluidigm Board of Directors Unanimously Recommends Stockholders Vote “FOR” ALL Proposals TODAY SOUTH SAN FRANCISCO, Calif. — Fluidigm Corporation (NASDAQ:FLDM), today announced that leading independent proxy advisory firms Institutional Shareholder Services (“ISS”) and Glass, Lewis & Co. (“Glass Lewis”) have recommended that Fluidigm stockholders vote “FOR” ALL proposals related to the previously announced strategic capital […]

ST. PAUL, Minn. — Scientific Bioprocessing, Inc. (SBI) and BioMADE announced today that up to 23 community and technical colleges will receive free state-of-the-art bioprocessing equipment through the SBI Digitally Simplified Bioprocessing Fellowship. The equipment – valued at up to $368,000 – will bring real-time solutions to biomass monitoring and bioprocessing technology training resources to […]

Kun Zhang and Arnold Kriegstein to Join Scientific Advisory Board, Lending Critical Expertise in Cell Biology SANTA CLARA, Calif. — Rebus Biosystems Inc, (“Rebus Bio”, “Rebus”), an Illumina Ventures-backed life science technology company creating revolutionary tools to advance spatial omics research, announced today that Arnold Kriegstein, M.D., PhD. and Kun Zhang, PhD., have been appointed […]

New funding to accelerate the scaling of operations and market introduction of its revolutionary “morpholomics” platform. MENLO PARK, Calif. — Deepcell, a life science company pioneering AI-powered single cell classification and isolation for basic and translational research, today announced that it has closed its $73 million Series B round of financing. The new funding will allow […]

New Chair brings extensive financial and life sciences experience with industry-leading companies SOUTH SAN FRANCISCO — Mission Bio, the pioneer in high-throughput single-cell DNA and multi-omics analysis, today announced it has appointed Stuart Essig, PhD, as Chair of its Board of Directors. Dr. Essig is currently a Managing Partner of Prettybrook Partners and Chairman of the […]

MENLO PARK, Calif. — Gamma Biosciences, a global life sciences company formed by KKR to serve the advanced therapy market with best-in-class bioprocessing solutions, today announced that Kieran P. Murphy will join its Board of Directors as Executive Chairman. With a long track record of building leading businesses in biopharma and life sciences, Mr. Murphy […]

Financing demonstrates the value of Laminar Wash technology in accelerating and standardizing therapeutic research and development WOBURN, Mass. — Curiox Biosystems, Inc., the global leader in biological sample preparation automation, announced today the completion of a $15 million (17.1 billion won) Series C financing round. Luha Private Equity led the deal, joined by other existing investors KB Investment Co., […]